Advanced SearchSearch Tips
BRCA1 Gene Mutations and Influence of Chemotherapy on Autophagy and Apoptotic Mechanisms in Egyptian Breast Cancer Patients
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
BRCA1 Gene Mutations and Influence of Chemotherapy on Autophagy and Apoptotic Mechanisms in Egyptian Breast Cancer Patients
Abdel-Mohsen, Mohamed Ahmed; Ahmed, Omiama Ali; El-Kerm, Yasser Mostafa;
  PDF(new window)
Background: It is well established that mutations in the BRCA1 gene are a major risk factor for breast cancer. Induction of cancer cell death and inhibition of survival are the main principles of cancer therapy. In this context, autophagy may have dual roles in cancer, acting on the one hand as a tumor suppressor and on the other as a mechanism of cell survival that can promote the growth of established tumors. Therefore, understanding the role of autophagy in cancer treatment is critical. Moreover, defects in apoptosis, programmed cell death, may lead to increased resistance to chemotherapy. Purpose: The aim of the present study was to detect BRCA1 gene mutations in order to throw more light on their roles as risk factors for breast cancer in Egypt. Secondly the role of autophagy and apoptosis in determining response to a fluorouracil, doxorubicin, cyclophosphamide (FAC) regimen was investigated. Materials and Methods: Forty-five female breast cancer cases and thirty apparently healthy females were enrolled in the present study. Serum levels of autophagic biomarkers, Beclin 1 and LC3 as well as the serum levels of apoptosis biomarkers Bcl-2 and Caspase-3 were measured before and after chemotherapy. Results: BRCA1 mutations were found in 5 (16.7%) and 44 (99.8%) of the controls and cancer patients, the most frequent being 5382insC followed by C61G and 185 delAG. The results revealed that chemotherapy caused elevation in serum concentration levels of the autophagic biomarkers (Beclin 1 and LC3). This elevation was associated with a significant decrease in serum concentration levels of Bcl-2 and significant increase in caspase-3 concentration levels (apoptotic markers). Conclusions: The results of the present study indicate a very high level of BRCA mutations in breast cancer cases in Egypt and point to involvement of autophagic and apoptotic machinery activation in response to FAC chemotherapy.
Breast cancer;BRCA1 gene mutation;autophagy;apoptosis;chemotherapy;
 Cited by
MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1, Clinical and Translational Oncology, 2017, 19, 9, 1133  crossref(new windwow)
Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway, Tumor Biology, 2017, 39, 5, 101042831769756  crossref(new windwow)
American Cancer Society (2012). Facts and Figures 2012. Atlanta. American Cancer Society

Ashton-Prolla P, Vargas FR (2014). Prevalence and impact of founder mutations in hereditary breast cancer in Latin America. Genetics and Molecular biology, 37, 234-40. crossref(new window)

Bellarosa D, Ciucci A, Bullo A, et al (2001). Apoptotic events in a human ovarian cancer cell line exposed to anthracyclines. J Pharmacology and Experimental Therapeutics, 296, 276-83.

Bensam M, Hafez E, Awad D, El-Saadani M, Balbaa M.(2014). Detection of new point mutations of BRCA1 and BRCA2 in breast cancer patients. Biochemical Genetics, 52, 15-28. crossref(new window)

Benson JR, Jatoi I (2012). The global breast cancer burden. Future Oncology, 8, 697-702. crossref(new window)

Burcoae T, Cimponeriu D, Ion DA, et al (2013). Analysis of several BRCA1 and BRCA2 mutations in a hospital-based series of unselected breast cancer cases. Chirurgia (Bucur), 108, 468-72.

Chan PC, Wong BY, Ozcelik H, Cole DE (1999). Simple and rapid detection of BRCA1 and BRCA2 mutations by multiplex mutagenically separated PCR. Clinical Chemistry, 25, 1285-87.

Choi JH, Cho YS, Ko YH, et al (2014). Absence of autophagyrelated proteins expression is associated with poor prognosis in patients with colorectal adenocarcinoma. Gastroenterology Research and Practice, 2014.

Dillenburg CV, Bandeira IC, Tubino TV, et al (2012). Prevalence of 185delAG and 5382insC mutations in BRCA1, and 6174delT in BRCA2 in women of Ashkenazi Jewish origin in southern Brazil. Genetics and Molecular Biology, 35, 599-602. crossref(new window)

Ding F, Shao ZW, Xiong LM (2013). Cell death in intervertebral disc degeneration. Apoptosis, 18, 777-85. crossref(new window)

Ding WX, Chen X, Yin XM (2012). Tumor cells can evade dependence on autophagy through adaptation. Biochemical and Biophysical Research Community, 425, 684-8. crossref(new window)

Ebied SA, El-Moneim NA, Hewala TI, Anwar MM, Rabi SM (2013). The diagnostic, prognostic and follow-up value of serum Bcl-2, Bax and p53 proteins in breast cancer patients: a comparison with serum CA 15-3. Middle East J Cancer, 4, 51-62.

El-Debaky FE, Azab NI, Alhusseini NF , Eliwa SK, Musalam HR (2011). Breast cancer gene 1 (Brca 1) mutation in female patients with or without family history in Qalubia governorate. J Am Sci, 7, 82-93.

El-Khattouti A, Selimovic D, Haikel Y, Hassan M (2013). Crosstalk between apoptosis and autophagy: molecular mechanisms and therapeutic strategies in Cancer. J Cell Death, 6, 37-55.

Freneaux P, Stoppa-Lyonnet D, Mouret E, et al (2000). Low expression of bcl-2 in Brca1-associated breast cancers. Br J Cancer, 83, 1318-22. crossref(new window)

Gao S, Yang XJ, Zhang WG, Ji YW, Pan Q (2009). Mechanism of thalidomide to enhance cytotoxicity of temozolomide in U251-MG glioma cells in vitro. Chinese Medical Journal, 122, 1260-6.

Grzybowska E, Sieminska M, Zientek H, Kalinowska E, Michalska J, Utracka-Hutka B, Rogozinska-Szczepka J, Kazmierczak-Maciejewska M (2002). Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population. Acta Biochimica Polonica, 49, 351-6.

Hammoud H, Saleh J, Bachour M, Salamoon M (2014). Serum caspase-3 and caspase-7 as predictive factors of response in locally advanced and metastatic breast carcinoma. Journal of Cancer Therapy, 5, 584-90 crossref(new window)

Jain K, Paranandi KS, Sridharan S, Basu A (2013). Autophagy in breast cancer and its implications for therapy. American Journal of Cancer Research, 3, 251-65.

King JS (2012). Mechanical stress meets autophagy: potential implications for physiology and pathology. Trends in Molecular Medicine, 18, 583-8. crossref(new window)

Lakshmi R, Vijayalakshmi S, Raju A, Joy TM (2013). Assessment of various risk factors of breast cancer. International Journal of Pharmacy and Pharmaceutical Sciences, 5, 675-8.

Liang XH, Jackson S, Seaman M, et al (1999). Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature, 402, 672-6. crossref(new window)

Mansilla S, Llovera L, Portugal J (2012). Chemotherapeutic targeting of cell death pathways. Anticancer Agents in Medicinal Chemistry, 12, 226-38. crossref(new window)

Marquez RT, Xu L (2012). Bcl-2: Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch. American J Cancer Res, 2, 214-21.

Mavaddat N, Peock S, Frost D, et al., (2013). Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRAC. J National Cancer Institute, 105, 812-22 crossref(new window)

McGuire A, Brown JA, Malone C, McLaughlin R, Kerin MJ (2015). Effects of age on the detection and management of breast cancer. Cancers (Basel), 7, 908-29. crossref(new window)

Montoya JE, Luna HG, Morelos AB, et al (2013). Association of creatinine clearance with neutropenia in breast cancer patients undergoing chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide (FAC). Medical Journal of Malaysia, 68, 153.

Noor S (2011). Loss of BRCA1 in normal human mammary epithelial cells induces a novel mechanism of senescence, university of toronto. department of medical biophysics, doctoral dissertation.

Nyhan MJ, O'Donovan TR, Elzinga B, et al (2012). The BH3 mimetic HA14-1 enhances 5-fluorouracil-induced autophagy and type II cell death in oesophageal cancer cells. Br J Cancer, 106, 711-8. crossref(new window)

Pan X, Zhang X, Sun H, et al (2013). Autophagy inhibition promotes 5-fluorouraci-induced apoptosis by stimulating ROS formation in human non-small cell lung cancer A549 cells. PloS one, 8, 56679. crossref(new window)

Park JM, Huang S, Wu TT, Foster NR, Sinicrope FA (2013). Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy. Cancer Biology and Therapy, 14, 100-7. crossref(new window)

Pohlreich P, Zikan M, Stribrna J, et al (2005). High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area. Breast Cancer Research, 7, 728. crossref(new window)

Ryter SW, Mizumura K, Choi AM (2014). The impact of autophagy on cell death modalities. Intern J Cell Biol, 2014, 502676.

Salem AF, Howell A, Sartini M, Sotgia F, Lisanti MP (2012). Downregulation of stromal BRCA1 drives breast cancer tumor growth via upregulation of HIF-$1{\alpha}$, autophagy and ketone body production. Cell Cycle, 11, 4167-73. crossref(new window)

Selimovic D, Porzig BB, El-Khattouti A, et al (2013). Bortezomib/proteasome inhibitor triggers both apoptosis and autophagy-dependent pathways in melanoma cells. Cell Signal, 25, 308-18. crossref(new window)

Su M, Mei Y, Sinha S (2013). Role of the crosstalk between autophagy and apoptosis in cancer. J Oncol, 2013, 1-14.

Tacar O, Dass CR (2013). Doxorubicin induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?. J Pharmacy and Pharmacol, 65, 1577-89. crossref(new window)

Tam CY (2010). Lifestyle and risk factors for breast cancer in postmenopausal caucasian and chinese-canadian women. university of toronto, medical science department, doctoral thesis.

Tang MK, Kwong A, Tam KF, et al (2014). BRCA1 deficiency induces protective autophagy to mitigate stress and provides a mechanism for BRCA1 haploinsufficiency in tumorigenesis. Cancer letters, 346, 139-47. crossref(new window)

Taylor K, Micha D, Ranson M, Dive C (2006). Recent advances in targeting regulators of apoptosis in cancer cells for therapeutic gain. Expert Opinion on Investigational Drugs, 15, 669-90. crossref(new window)

Teng DHR, Bogden R, Mitchell J, et al (1996). Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nature Genetics, 13, 241-4. crossref(new window)

Ward H, Cummings J, Dean E, et al (2008). Biomarkers of apoptosis. Br J Cancer, 99, 841-6. crossref(new window)

Young MM, Kester M, Wang HG (2013). Sphingolipids: Regulators of crosstalk between apoptosis and autophagy. Journal of Lipid Research, 54, 5-19. crossref(new window)

Zeeneldin AA, Ramadan M, Gaber AA, Taha FM (2013). Clinico-pathological features of breast carcinoma in elderly Egyptian patients: A comparison with the non-elderly using population-based data. Journal of the Egyptian National Cancer Institute, 25, 5-11. crossref(new window)

Zhao C, Yin S, Dong Y, et al (2013). Autophagy-dependent EIF2AK3 activation compromises ursolic acid-induced apoptosis through upregulation of MCL1 in MCF-7 human breast cancer cells. Autophagy, 9, 196-207. crossref(new window)